Conduit Historical Financial Ratios
| CDT Stock | 0.11 0.01 11.00% |
Conduit Pharmaceuticals is presently reporting on over 73 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, Days Sales Outstanding of 0.0 or Invested Capital of 0.0 will help investors to properly organize and evaluate Conduit Pharmaceuticals financial condition quickly.
Conduit |
About Conduit Financial Ratios Analysis
Conduit PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Conduit Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Conduit financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Conduit Pharmaceuticals history.
Conduit Pharmaceuticals Financial Ratios Chart
Add Fundamental
Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Return On Equity
Return on Equity is the amount of Conduit Pharmaceuticals net income returned as a percentage of Conduit Pharmaceuticals equity. Return on equity measures Conduit Pharmaceuticals profitability by revealing how much profit Conduit Pharmaceuticals generates with the money shareholders have invested. A measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity.Most ratios from Conduit Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Conduit Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Conduit Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.
| 2010 | 2022 | 2023 | 2024 (projected) | ROE | 0.62 | 0.49 | 1.17 | 0.61 | Income Quality | 0.59 | 0.46 | 14.44 | 15.16 |
Conduit Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Conduit Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.